The largest database of trusted experimental protocols

Streptomycin

Manufactured by R&D Systems
Sourced in United States

Streptomycin is a broad-spectrum antibiotic used in laboratory research settings. It is effective against a wide range of bacterial species, including both Gram-positive and Gram-negative bacteria. Streptomycin functions by inhibiting protein synthesis in bacterial cells, thereby disrupting their ability to grow and replicate.

Automatically generated - may contain errors

43 protocols using streptomycin

1

Isolation and Culture of Primary Schwann Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary Schwann cells cultures were obtained from sciatic nerves harvested from adult Sprague Dawley rats. The nerves were collected in cold DMEM plus glutamax (Gibco, Carlsbad, CA, USA) containing 100 U/mL penicillin (R&D system, Minneapolis, MN, USA) and 100 g/mL Streptomycin (R&D system, Minneapolis, MN, USA). Nerves were then gently dissected and the epineurium removed with fine forceps. Fragments of nerves were then plated in 35 mm petri dishes and incubated with glial permissive medium (DMEM plus glutamax, 100 U/mL penicillin and 100 g/mL Streptomycin, 14M forskolin and 100 ng/mL LNRG11; R&D System, Minneapolis, MN, USA) for 2 weeks under culture conditions (37°C, 5% CO2). The medium was replenished every 72 hours. The culture medium was then enriched with 0.125% collagenase type IV (ThermoFisher, Lafayette, CO, USA) and 117 U/mg dispase (Gibco) for 24 hours and mechanically dissociated with a Pasteur glass pipette. The cell suspension was filtered through a 70 µm cell strainer (BD Biosciences) and centrifuged at 100 × g for 5 minutes. The cell pellet was resuspended in glial permissive medium, seeded on 35 mm petri dishes pre-coated with poly-D-lysine (Sigma) and incubated under culture conditions. An antibody complement method was adopted to purify Schwann cells from fibroblasts (Tohill et al., 2004; Kaewkhaw et al., 2012; Pascal et al., 2014).
+ Open protocol
+ Expand
2

Differentiation and Culture of Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse bone marrow-derived mast cells (BMMC) were differentiated from the marrow of tibias and femurs of Wt and Ptch1+/− littermate mice and cultured for at 6-8 weeks in RPMI 1640 supplemented with 10% FBS, HEPES (1M), penicillin (100 U/mL), streptomycin, 4 mM L-glutamine (100 μg/mL), sodium pyruvate (1 mM), 2-mercaptoethanol (50 μM), and IL-3 (30 ng/mL, R&D Systems). Cultures were analyzed by flow cytometry and BMMC were identified as FcϵRI and Kit double positive cells as described above. Degranulation assays of BMMC were performed as described (26 (link)).
HMC-1.1 and HMC-1.2 cell lines were cultured in Iscove’s Modified Dulbecco’s Medium supplemented with 10% FBS, L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 μg/ml). LAD2 cells were cultured in StemPro-34™ supplemented with StemPro-34™ Nutrient Supplement (Gibco), L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 μg/ml), and SCF (100 ng/ml, R&D Systems).
Primary human mast cell cultures (hMC) were derived from CD34+ lymphocytapheresis progenitors obtained from healthy volunteers following informed consent under a protocol (NCT00001756) approved by the National Institutes of Health Internal Review Board. Cells were cultured as described (27 (link)) and used between 7–9 weeks of culture when >95% were mast cells identified as KIT and FcεRI double positive cells.
+ Open protocol
+ Expand
3

Murine Macrophage Differentiation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were isolated from bone marrow of C57BL/6 wild-type or Caspase-1/ (Jackson Laboratory) female mice (7–8 weeks old) and differentiated for 7 days in RPMI 1640 medium supplemented with 10% fetal bovine serum (Gibco), penicillin (100 U/ml) and streptomycin (0.1 mg/ml) and 20 ng/ml human M-CSF (R&D Systems). THP-1 (Cell Bank of Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences) were cultured in RPMI 1640 medium with FBS and penicillin and streptomycin. Phorbol 12-myristate 13-acetate (100 ng/ml, 24 h) was used in differentiation of THP-1 into macrophages. The additives or inhibitors used in in vitro experiments are as follows: purified SAK (0.5 μg/ml), lipopolysaccharide (LPS, 0.2 μg/ml), ATP (5 mM), MCC950 (1 μM, Selleck), potassium channel blocker glibenclamide49 (link) (10 μM, Sigma), KCl (25 mM), NADPH oxidase inhibitor apocynin50 (link) (200 μM, Selleck), lysosome membrane stabilizer dexamethasone51 (link) (200 nM, Sangon Biotech), ROS scavenger NAC52 (link) (1 mM, Sigma), and NF-κB inhibitor BAY 11-7082 (10 μM, Sigma).
+ Open protocol
+ Expand
4

Plasmacytoid Dendritic Cell Cytokine Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated pDCs (5 × 104 cells/96-well cavity) were seeded in 200 µl of RPMI 1640 medium (Thermo Fisher Scientific) supplemented with 100 IU ml−1 penicillin, 100 µg ml−1 streptomycin, 2 mM l-glutamine, 10% (vol/vol) human serum and recombinant human (rh) IL-3 [10 ng ml−1; R&D Systems]. To determine the levels of secreted IFNα, pDCs were cultured for 12–14 h in the presence of ODN 2216 (CpG A; 0.26 µM; Thermo Fisher Scientific). To block p75NTR activity, the inhibitory peptide TAT-Pep5 (100 nM, Merck) was added. Recombinant human β-NGF (R&D Systems) was added at the indicated concentrations. The IFNα levels in supernatants were determined using an ELISA (eBioscience). To determine the levels of secreted IL-6, pDCs were stimulated with an antibody specific to human FcεRlα (250 ng ml−1; eBioscience) alone or in the presence of the TAT-Pep5 inhibitor. Recombinant human β-NGF was added at the indicated concentrations. After 14 h, the supernatant was collected to measure IL-6 levels using an ELISA (eBioscience).
+ Open protocol
+ Expand
5

Chondrocyte Encapsulation in Alginate Beads

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATDC5 cells were suspended at a density of 2 × 106 cells/ml in a 1.2% solution of sterile alginate (Kelco, Chicago, IL) in 0.15 M NaCl. The cell suspension was slowly expressed through a 22-gauge needle dropwise into a 100 mM calcium chloride solution. Beads were allowed to polymerize in this solution for 10 min before two consecutive washes with 0.15 M NaCl followed by two washes in DMEM/F12. After washing, beads containing ATDC5 cells were then placed into 12-well culture plates (10 beads/well) in 2 ml of DMEM/F12 containing 5% FBS, penicillin (100 μg/mL)-streptomycin (50 μg/mL), insulin-transferrin-selenium, recombinant human bone morphogenetic protein (BMP)-2 (0.25 μg/mL, R&D Systems, Minneapolis MN), and 50 μg/ml ascorbic acid. ATDC5 cells were cultured in alginate beads with the growth medium containing insulin-transferrin-selenium and BMP-2 for 6 days. Medium was changed once in three days. Medium was then removed from individual wells, and the beads were dissolved by incubation for 10–15 min at 4 °C in dissolving solution (55 mM sodium citrate, 30 mM Na2EDTA, 0.15 M NaCl, pH 6.8). The resulting suspension was centrifuged at 900 rpm for 10 min at 4 °C to separate the ATDC5 cells.
+ Open protocol
+ Expand
6

Establishing Primary and Cell Line Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from American Type Culture Collection and tumor cells from bone marrow (BM) aspirates following written informed consent under an Institutional Review Board approved protocol. Cells were cultured in RPMI1640 (Life Technologies) with 10% fetal bovine serum (FBS), 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (100 μg/ml) and cytokines (10 ng/ml IL7, FLT3-L and SCF; R&D Systems, Minneapolis, MN). Cell lines were cultured similarly without cytokines. OP9 murine stromal cells were expanded in DMEM with growth additives before co-culture with primary ALL blasts.
+ Open protocol
+ Expand
7

Osteogenic Differentiation of Rat and Human MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in-vitro study, human mesenchymal stem cells (hMSCs, RoosterBio Inc., MD, USA) were cultured using MSC expansion media (R&D Systems, MN, USA) (growth media; GM) supplemented with Penicillin (100 IU/ml) - Streptomycin (100 μg/ml) (cat. no. 30–002-CI, Corning Life Sciences, Lowell, MA) until usage. As an osteogenic media (OM), human osteogenic differentiation media (Cell Applications, USA) added with Penicillin-Streptomycin was used.
For in-vivo study, as implantation of hMSCs was not possible into immunocompetent rats, allogenic rBMSCs were extracted from inbred 4-week-old male Fischer white rats (F344/DuCrl, Charles River Laboratories, Wilmington, MA) [25 ]. All animals were cared in the animal facility (Millennium Science Complex, PSU) and euthanasia procedures were according to American Association for Laboratory Animal Science (AALAS) and The Institutional Animal Care and Use Committee (IACUC protocol #46591). Isolated rBMSCs were plated on 6-well cell culture plates in Minimal Eagle’s Medium, Alpha modification (αMEM; cat. no. 10–022-CV, Corning Cellgro®, Manassas, VA) supplemented with 10% fetal bovine serum (FBS) (cat. no. 35–010-cv, Thermo Fisher Scientific, Waltham, WA), PS and 2.5 μg/ml Fungizone (cat. no. 15–290-026, Thermo Fisher Scientific) and incubated at 37 °C in a humidified 5% CO2 incubator.
+ Open protocol
+ Expand
8

Osteoclast Differentiation from Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen cells were isolated from 4- to 6-week-old WT or src−/− mice and cultured under 5% CO2 at 37 °C in alpha modification of Eagle's minimum essential medium from Sigma-Aldrich supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 μg/ml) with human macrophage colony-stimulating factor (30 ng/ml) from R&D Systems Inc for 3 days, and then, the cells (100,000 cells/well, in a 24-well plate) were replated on culture plates from Corning, coverslips (Fisher Scientific), or dentin slices and cultured with human soluble RANKL (100 ng/ml) from R&D Systems Inc for 5 days. Cells were infected with adenoviruses expressing cre recombinase (CRE) (multiplicity of infection [MOI] 50) and Src family kinases or chimeras (MOI 50) on day 4 after replating and culture for 1 day.
+ Open protocol
+ Expand
9

Isolation and Culture of HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary HUVECs were collected from human umbilical veins by digestion in 0.1% collagenase I in M199 medium (Gibco, NY, USA) for 15 min. The solution was collected and centrifuged at 1000 rotations per minute (rpm) for 10 min. The cells were cultured in M199 medium that contained 10% fetal bovine serum (Gibco, NY, USA), 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 20 ng/ml endothelial growth factor (R&D, Minneapolis, MN, USA) in an incubator at 37°C and 5% CO2. HUVECs from passage 3 were used in the present study.
+ Open protocol
+ Expand
10

Isolation and Culture of Bone Marrow-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived DCs (BMDCs) were isolated from the bone marrow cells of C57BL/6 (H-2b) mice.26 (link) Briefly, bone marrow was collected from the tibias and femurs by flushing with RPMI 1640 using a 1 mL syringe with a 26 G needle (BD Biosciences, San Jose, CA, USA). After one wash (490×g, 5 minutes) in RPMI 1640 medium, the cells were incubated with 5 mL of 0.83 M NH4Cl buffer (Sigma-Aldrich) to lyse red blood cells at 37°C for 5 minutes. Then, cells were centrifuged twice in RPMI 1640 medium at 150×g. The bone marrow cells (2×106 cells) were collected and cultured in 100 mm petri dishes (BD, Franklin Lakes, NJ, USA) containing 10 mL of the RPMI 1640 medium supplemented with 10% of heat-inactivated fetal bovine serum, 50 IU/mL penicillin, 50 mg/mL streptomycin, and 20 ng/mL mouse recombinant granulocyte-macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN, USA). After 7 days, nonadherent and loosely adherent cells (immature DCs) were harvested, washed, and used for in vitro experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!